GF
SUPN icon

Gerstein Fisher’s Supernus Pharmaceuticals SUPN Stock Holding History

Gerstein Fisher’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-45,574
Closed -$695K – 436
2016
Q1 		$695K Buy
45,574
+324
+0.7% +$4.23K 0.09% 177
2015
Q4 		$608K Hold
45,250
– – 0.08% 198
2015
Q3 		$635K Hold
45,250
– – 0.1% 190
2015
Q2 		$768K Buy
+45,250
New +$644K 0.12% 168

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gerstein Fisher's SUPN Position: Q2 2016 in Review

Gerstein Fisher sold out of Supernus Pharmaceuticals (SUPN) in Q2 2016, closing a stake of 45,574 shares — an estimated $695K sold.

Gerstein Fisher first reported a position in SUPN in Q2 2015 and held it in 4 quarters. The position peaked at $768K in Q2 2015. 215 funds tracked by Wall St. Rank hold SUPN as of Q2 2016.

  • Gerstein Fisher reported no remaining Supernus Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Gerstein Fisher sold 45,574 Supernus Pharmaceuticals shares in Q2 2016, an estimated $695K.
  • Gerstein Fisher first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Gerstein Fisher's Supernus Pharmaceuticals position peaked at $768K in Q2 2015.
  • 215 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2016.

Based on Gerstein Fisher's 13F filing for Q2 2016, filed 8 Aug 2016.